United States · 
What does Telegraph Hill Partners invest in?
Telegraph Hill Partners invests most often at Series B and Series C (54% of the rounds on record), in sectors such as Life Sciences, Healthcare and Medical Devices.
Telegraph Hill Partners highlights
- 01
16 rounds on record
- 02
Mostly Series B and Series C: 54% of its rounds
- 03
Sole investor in 4 rounds, median $9.8M
- 04
7 exits from the portfolio
What they do
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives.From their own website
- Type
- VC firm
- Cheque size
- Not stated
- Stages
- Growth
- Sectors
- Life SciencesHealthcareMedical Devices
- Based in
- San Francisco, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first16 appearances
- 2017
1 round
- Nov
- 2015
1 round
- Sept
- 2012
1 round
- Aug
- 2011
1 round
- Jan
- 2010
1 round
- Dec
- 2009
2 rounds
- Oct
- Jun
- 2008
2 rounds
- Dec
- Jan
- 2007
5 rounds
- Dec
- Oct
- Sept
- Mar
- Jan
- 2006
1 round
- Jun
- 2004
1 round
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
DADeval A LashkariSenior PartneriForm ADV
JMJ. Matthew MackowskiManaging Director of the Managing Member of the General Partner.iFiling they signed
JMJeanette Marie WelshPartner, Chief Operating OfficeriForm ADV
JMJohn Matthew MackowskiChairman, Managing DirectoriForm ADV
RGRobert G. SheplerMember of the Managing Member of the General Partner.iFiling they signed
TAThomas Alfred RaffinVenture PartneriForm ADV
We also hold 18 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.2Bgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Telegraph HILL Partners Management Company LLC
- SEC number
- CRD 160448
What they claim to have backed
From their own portfolio page (on their website)
8 of 23 we have independently watched raise
AkoyabioCellmicrosystemsEtherfaxFrontierInvisalertsolutionsKytopenRevmedicatelegraph hill partners CarterraArgonautmsDynextechnologiesEditcoHtslabsMitostudiosMosaicbioN6tecNimbletherapeuticsPanomebioPromptlycheckinWelconytelegraph hill partners ETStelegraph hill partners Nivagentelegraph hill partners Teknovatelegraph hill partners TrakCel
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed7 in all
AngioScoreBought by Spectranetics$230MMay 2014
EstechBought by AtriCure$60MDec 2013
LDR HoldingListed$75MOct 2013
AccumetricsBought by ITCUndisclosedAug 2013
Althea TechnologiesBought by AjinomotoUndisclosedMar 2013
ConfirmaBought by Merge HealthcareUndisclosedAug 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.